ICPR 2016: Robin Carhart-Harris – Brain imaging and depression research with psychedelics

ICPR 2016: Robin Carhart-Harris – Brain imaging and depression research with psychedelics

Brain imaging and depression research with psychedelics

The talk will review brain imaging work on the action of psychedelics on the brain and describe the results of a clinical trial assessing psilocybin as a treatment for depression. It will also review the broader societal impact of psychedelic drug-use and discuss its implications.

Biography

Robin Carhart-Harris studies the brain effects of LSD, psilocybin (magic mushrooms), and MDMA. Most recently he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat depression.

By | 2017-12-22T00:53:03+00:00 22 June 2016|